Ticker: VNDA

Company: Vanda Pharmaceuticals Inc.

Person: Tage Honore, director

Transaction date: Feb. 23, 2026

Reporting date: Feb. 24, 2026

Average share price: 8.03

Sold 30000.0 shares for 240900.0